Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 24.68 USD 0.73% Market Closed
Market Cap: 3.6B USD
Have any thoughts about
Denali Therapeutics Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-7.5
Current
-8.4
Median
5.7
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-7.5
=
Enterprise Value
2.7B USD
/
Operating Cash Flow
-362.7m USD
All Countries
Close
 
US
Denali Therapeutics Inc
NASDAQ:DNLI
Average EV/OCF: 22.6
Negative Multiple: -7.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -237 522.5
US
Abbvie Inc
NYSE:ABBV
22.5
US
Amgen Inc
NASDAQ:AMGN
26.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -132.5
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474
AU
CSL Ltd
ASX:CSL
35.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.2
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.9

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More